Status:
TERMINATED
Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborating Sponsors:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Conditions:
Diabetes Mellitus
Percutaneous Coronary Intervention
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant defense) and inflam...
Eligibility Criteria
Inclusion
- Patients with Diabetes Mellitus submitted to Percutaneous Coronary Intervention with Stent bare metal
- Age: 18-80 years old
Exclusion
- Restenosis
- Drug elution stent
- Acute coronary syndrome at last 30 days
- Use anti inflammatory, antibiotic, vitamin E
- Inflammatory disease or oncologic
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2009
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00967642
Start Date
August 1 2006
End Date
April 1 2009
Last Update
August 28 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.